Fengycins From Bacillus amyloliquefaciens MEP 2 18 Exhibit Antibacterial Activity by Producing Alterations on the Cell Surface of the Pathogens Xanthomonas axonopodis pv. vesicatoria and Pseudomonas aeruginosa PA01.

MLA

Medeot, Daniela B., et al. “Fengycins From Bacillus Amyloliquefaciens MEP 2 18 Exhibit Antibacterial Activity by Producing Alterations on the Cell Surface of the Pathogens Xanthomonas Axonopodis Pv. Vesicatoria and Pseudomonas Aeruginosa PA01.” Frontiers in Microbiology, vol. 10, Jan. 2020, p. 3107. EBSCOhost, https://doi.org/10.3389/fmicb.2019.03107.

APA

Medeot, D. B., Fernandez, M., Morales, G. M., & Jofré, E. (2020). Fengycins From Bacillus amyloliquefaciens MEP 2 18 Exhibit Antibacterial Activity by Producing Alterations on the Cell Surface of the Pathogens Xanthomonas axonopodis pv. vesicatoria and Pseudomonas aeruginosa PA01. Frontiers in Microbiology, 10, 3107. https://doi.org/10.3389/fmicb.2019.03107

Chicago

Medeot, Daniela B, Maricruz Fernandez, Gustavo M Morales, and Edgardo Jofré. 2020. “Fengycins From Bacillus Amyloliquefaciens MEP 2 18 Exhibit Antibacterial Activity by Producing Alterations on the Cell Surface of the Pathogens Xanthomonas Axonopodis Pv. Vesicatoria and Pseudomonas Aeruginosa PA01.” Frontiers in Microbiology 10 (January): 3107. doi:10.3389/fmicb.2019.03107.